The VISION Trial: Tepotinib in Patients With NSCLC Harboring METex14 Skipping Mutation
The VISION Trial: Tepotinib in Patients With NSCLC Harboring M…
143 viewsMay 10, 2024
vumedi.com
ESMO 2021 Efficacy and Safety of Tepotinib in Patients With Advanced Age: VISION Subgroup Analysis of Pts With MET Exon 14 Skipping NSCLC
ESMO 2021 Efficacy and Safety of Tepotinib in Patients With Advanc…
42 viewsOct 20, 2021
vumedi.com
Dr. Paik on Tepotinib in METex14-Mutated NSCLC | OncLive
Dr. Paik on Tepotinib in METex14-Mutated NSCLC | OncLive
Jun 27, 2019
onclive.com
Dr. Garassino on the Clinical Implications of Tepotinib in METex14-Altered NSCLC | OncLive
Dr. Garassino on the Clinical Implications of Tepotinib in METe…
Sep 24, 2021
onclive.com
Dr Paik on the Full FDA Approval of Tepotinib for mNSCLC Harboring MET Exon 14 Skipping Alterations | OncLive
1:21
Dr Paik on the Full FDA Approval of Tepotinib for mNSCLC Harboring …
Mar 30, 2024
onclive.com
Dr. Le on the Rationale for Tepotinib in METex14-Mutant NSCLC | OncLive
Dr. Le on the Rationale for Tepotinib in METex14-Mutant NSCLC | OncL…
Jun 9, 2020
onclive.com
Recent Advances in Treatment of MET Exon 14 Skipping Mutations in NSCLC | OncLive
Recent Advances in Treatment of MET Exon 14 Skipping Mutations i…
May 5, 2022
onclive.com
Disponibile in Italia tepotinib per il carcinoma polmonare | MilanoFina…
May 1, 2023
milanofinanza.it
MET Exon 14 Skipping Mutations in NSCLC | OncLive
1 month ago
onclive.com
Overview of MET Amplification and MET Exon 14 Skipping Mutations i…
Dec 7, 2021
targetedonc.com
5:50
MET Exon 14 Splice Site Mutations: A Comprehensive Review of Appr…
1 views4 months ago
YouTubeUniversal Story Hub
MET Inhibitors in NSCLC: Treatment Selection | OncLive
Apr 19, 2021
onclive.com
1:11
Xiuning Le, MD, PhD, discusses the mechanism of action for tepotani…
25 viewsJun 5, 2020
YouTubeOBRoncology
2:47
Key Points about MET in Lung Cancer
2.7K viewsJan 22, 2021
YouTubeAmerican Lung Association
1:13
Dr. Reckamp on Pivotal Data in METex14-Altered NSCLC
262 viewsJul 26, 2019
YouTubeOncLive
13:06
MET Exon 14 Mutations in mNSCLC
1.1K viewsSep 3, 2020
YouTubeOncLive
3:23
Tepotinib in MET-amplified NSCLC: real-world outcomes from Australia
66 views3 months ago
YouTubeVJOncology
26:43
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 1
25 views6 months ago
YouTubeDecera Clinical Education
2:39
Trial VISION: long-term outcome di tepotinib nel NSCLC METex14
86 views5 months ago
YouTubeOncoInfoTV
Dr. Pecot on Selecting Between Available Targeted Therapies in N…
Sep 15, 2021
onclive.com
Characteristics of the MET Exon 14 Skipping Mutation NSCLC Populat…
Dec 1, 2021
targetedonc.com
59:37
Refining Biomarker Testing and Targeted Treatment of NSCLC Wit…
1K viewsNov 8, 2022
YouTubePeerView Oncology
3:35
The Availability of MET Inhibitors for NSCLC
252 viewsMar 23, 2020
YouTubeTargeted Oncology
3:13
TEPMETKO® (tepotinib)- Non-Small Cell Lung Cancer
17 views3 months ago
YouTubePharmacy Talk USA
2:28
Tepotinib in advanced nsclc patients - ASCO 2018
624 viewsJun 2, 2018
YouTubeEinstein Hospital Israelita
8:14
Tepotinib Synthesis
50 views4 months ago
YouTubeChemSynth
7:33
Tepotinib [1/2] METex14 비소세포폐암에서의 테포티닙
3 views1 month ago
YouTube혈종노트: Hem-Onc Note by H1
1:42
特泊替尼: 给METex14非小细胞肺癌患者带来新希望【上海医家依】
6 months ago
bilibili老挝卢修斯制药
MET Inhibitors in NSCLC: Toxicity Management | OncLive
Apr 19, 2021
onclive.com
HER2 Targeted Therapy for Treatment of NSCLC | OncLive
Sep 1, 2020
onclive.com
See more videos
Static thumbnail place holder